GENEXI initial coin offering (ICO)

Accelerating Biotech Breakthroughs



There are many challenges facing the biotech industry today, such as quality assurance, counterfeiting and research intransparency. GENEXI is determined to deliver a holistic solution in the form of a transparent and comprehensive blockchain-based ecosystem on to the market. Within GENEXI Ecosystem biotech start-ups and projects will be able to find financial and advisory support to establish and scale-up their production. Upon entering the GENEXI Platform, distributors will be able to provide their services and build networks with vendors, while regular customers will gain an access to complete immutable data about the products. At the same time, third-party service providers will be able to present their support to other participants of the community. GENEXI plans to integrate its unique blockchain solution throughout the entire supply chain management process in order to fight drug counterfeit, fraud and quality manipulation and ensure full transparency at every level.

4.7
10 10 expert ratings
4.1
4.9
4.7
4.4
View rating distribution
Starts in 1 year ago
2018-06-01 - 2018-09-10
Token
GEN Token
Type
ERC20
Bonus
Available
Price in ICO
1 GEN = 0.01 USD
Platform
Soft cap
20,000,000 USD
Hard cap
70,000,000 USD
Raised
37000000
preICO start
May 1, 2018
preICO end
May 31, 2018
ICO start
Jun 1, 2018
ICO end
Sep 10, 2018
More on ICO
Report

About GENEXI ICO

GENEXI combines the expertise of renowned specialists in the biotech industry to create a thriving ecosystem for biotech strartups and established pharmaceutical companies of different sizes and levels of operation.

GENEXI Foundation is an organisation employing a wide range of high-profile biotech professionals to provide manual heuristic analysis for the most detailed venture assessment and evaluation.

GENEXI Foundation will use its expertise and funds to select the most promising biotech startups for grant awarding.

GENEXI Platform is an innovative solution provided by the GENEXI Dev Team for the e-commerce market in order to support GENEXI Ecosystem development. The Platform will unite biotech producers, distributors, retailers and end-consumers in one blockchain-based solution operating as a global ecosystem.

GENEXI reviews

James Sowers
Ico adviser
Rated on May 15, 2018
5
5
5
9%

Great concept a biotech accelerator providing a Blockchain based solution!

Nikolay Shkilev
PhD | Entrepreneur | CEO | ICO Advisor | Crypto enthusiast | Blockchain expert | Public speaker | Mentor
Rated on May 27, 2018
5
5
4
11%

UPD: Good and big team.
Great vision. And biotech is huge market.
MVP - will soon!
KYC - passed it's good
Vision is good
Need more strong marketing and PR

Nikolay Zvezdin

Rated on May 17, 2018
5
5
4
7%

Big and experienced team is one of the main advantages of this project, however, I would strongly recommend passing KYC, and showing the actual product in order to improve transparency.

Hung Chih (Jason Hung)
Serial Entrepreneur | Investor Meetup | ICO advisor | China Market | Exchange
Rated on May 19, 2018
5
5
4
11%

The project intend to build transparency ecosystem for biotech and encourage the participation by using token as a media. It's a good direction and I looking forward to see it works.

However, from my many years experience of doing business with biotech, the player in biotech industry is usually very conservation and self-protected.

So, I think the challenge is not technology but how to promote and convincing all player. The core team is strong, but I will recommend invite more channel and sales partner to speed up market adaption.

Good luck!

Vlad Skakun
Cryptocurrency Enthusiast | Senior Analyst at Venture Fund
Rated on May 21, 2018
5
5
5
7%

Nowadays biotech industry is very promising and implementation blockchain technology in it could provide a great competitive advantage to the project.

GENEXI wants to create not just some local solution but a complex product which will help to solve the problem of the supply chain, drug counterfeit, fraud and quality manipulation.

They have a solid and experienced team in the business sphere. Their MVP will be launched in Q3 this year, keep waiting.

Vladimir Manzyuk
Blockchain/System Analyst
Rated on May 24, 2018
5
5
5
8%

In my opinion:
- Good team
- Nice vision
- The fact that the company is registered in Switzerland is a big plus for investors
- The market has high CAGR

Suraj Tiwari
ICO ADVISOR / CONSULTING / EXCHANGES Listing /SMART CONTRACT/ TOKEN CODE.
Rated on Jun 14, 2018
3
4
3
5%

Team : looks great but when checked linked most of them either dont have it or have few connections.

Vision is good but i think they have to work very hard for it.

Product : cant see any prototype though the website was awesome but cant rate a website.

Igor Karavaev
ico advisor and investor
Rated on Jul 4, 2018
5
4
5
11%

The biotech industry has a great perspective using blockchain. This team is reinforced and quite numerous. This is a project with a good potential if well implemented. The WP still should be a bit improved as comes to numbers.

Brian Condenanza
Entrepreneur | Editor @ RevistaBitcoin | ICO Advisor
Rated on Sep 7, 2018
5
4
4
9%

Very interesting product, although this is a very hard ecosystem to break in, as biotech breakthroughs can be very expensive to get. Great team and advisory board. Good luck team!

PlumBot
ICO Analyzer Bot
Rated on Oct 10, 2018
0
0
0
24%


Experts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.

Ratings and ICO analyzer results are being updated (re-calculated) every few hours.

GENEXI ICO price

Price in ICO

1 GEN = 0.01 USD

GENEXI (GEN Token) crypto

GENEXI coin

GENEXI token
GEN Token
GENEXI type
ERC20
GENEXI platform

GENEXI (GEN Token) value

Tokens for sale
8400000000

GENEXI market cap

GENEXI market capitalization
$ 37000000

GENEXI investment info

Distributed in ICO
70%
Soft cap
20,000,000 USD
Hard cap
70,000,000 USD

GENEXI whitepaper

GENEXI team

Apply as an advisor

Katrina Arden

Escrow

Alexey Zhelyaskov

Founder, CEO

Alexey Kirillov

Co-Founder, COO

GENEXI milestones

1
2014

WePower idea

2
2020

WePower idea

3
H1 2019

WePower idea

4
H2 2019

WePower idea

5
Q1 2017

WePower idea

6
Q1 2018

WePower idea

7
Q3 2017

WePower idea

8
Q3 2018

WePower idea

9
Q4 2018

WePower idea

ICOs that might interest you

MB8 Coin will be used as the ‘fuel’ for the existing Multibuy loyalty rewards network.

May 7, 2018

An innovative, disruptive, decentralised and democratised solar energy ecosystem that offers cle...

Jan 1, 2019

Litenett - is a new European social network with decentralized payment system on Blockchain for t...

Dec 3, 2018

Millions of people read news on a daily basis. The MulTra News App pays you for reading news.

Jun 9, 2018